SUMMARY Twenty-four episodes of genital herpes in 22 men, all confirmed by virus isolation, were studied in a double blind trial. They were treated either with 3 % adenine arabinoside (Ara-A) in petrolatum ointment base or with the base alone applied four times daily for one week. The lesions were counted and sketched on days 0, 2, and 7. There was no demonstrable advantage to be gained from the use of Ara-A ointment. The results of the Papanicolaou smears and virus isolation agreed in the diagnosis of 75 % of cases.
Introduction
There is a continuing need to study antiviral drugs that may inhibit or kill genital herpes simplex virus (HSV) Type 2. A primary infection in the male is usually painful and will last between two and three weeks or longer, whereas a recurrent attack is more likely to be relatively painless and transient, or to persist for less than two weeks. The female partner on the other hand can occasionally develop more extensive and painful lesions of the genitalia and if the cervix is affected there can be serious sequelae. Most experimental drugs so far investigated are purine and pyrimidine derivatives. Adenine arabinoside (vidarabine, Vira-A, Ara-A) is a purine nucleoside (9-B-D-arabinofuranosyladenine) which has been shown to be active against deoxyribonucleic acid (DNA) viruses, including members of the herpes group (Schabel, 1968) . Its therapeutic effect in life-threatening DNA viral infections (Keeney and Buchanan, 1975) , including those in immunosuppressed patients (Ch'ien et al., 1976) , is being assessed and if drug toxicity occurs it appears to be dose related (Ross et al., 1976) . Topical application in the treatment of herpetic infections of the eye has had encouraging results (Pavan-Langston et al., 1973; Coster et al., 1976) .
Three per cent Ara-A in petrolatum ointment base was made available for evaluation in the treatment of genital herpes in the male. As all herpetic infections are subject to latency, chronicity and recurrence, a double blind randomised comparison with a petrolatum placebo was used, each preparation being administered for seven days. Dry swabs were used for collecting material for the culture of HSV from patients on their initial visit and on more than 80% of the subsequent attendances when ulcers or blisters were present. The cottonwool swabs were transported in 50 % skimmed milk in saline (Clarke et al., 1964) . Each specimen was inoculated into cultures of human embryo fibroblasts and Hep 2 cells on the day of receipt, except for specimens taken after routine laboratory hours which were processed the following day. The identity of the isolates was confirmed by neutralisation with specific herpes simplex antiserum and then Types 1 and 2 were differentiated by (a) the cytopathic effect in BHK-21 cells (Smith et al., 1973) and (b) the nature of the lesions produced on the chorioallantoic membrane of fertile hens' eggs when inspected at seven days (Parker and Banatvala, 1967) . Papanicolaou smears were prepared from scrapings of the penile lesions with a coverslip when the patients first attended, and again from 40% of the lesions which were swabbed for virus isolation during the trial period. Each patient was supplied with either Ara-A or the vehicle ointment in a double blind randomised trial with instructions to apply the ointment four times daily for one week. No attempt was made to confirm that the ointment was regularly applied other than to request that used and unused tubes be returned at the end of treatment. After their first attendance patients were seen 48 hours later (day 2), at the end of the treatment (day 7), and at the end of the trial period (day 28). Results Thirty-one patients took part in the trial, contributing 34 episodes of herpes genitalis. Five patients had histories of some form of allergy, and nine had received local applications to the skin. One patient received metronidazole and another erythromycin for accompanying tonsillitis during the seven days of treatment. The dlinical features and the results of investigations carried out on presentation are listed in Table 1 Tables 2 and 3) . Table 3 confirms the well established facts that first attacks of herpes simplex virus infection are associated with a greater number of lesions and take longer to heal than recurrences. At the end of a week's treatment with either placebo or Ara-A, 56 % of the recurrences had healed compared with only 20% of the first attacks. Fresh lesions were observed in some patients during the seven days of treatment, during the next three weeks of the trial, and in the subsequent months when patients returned to the department for further advice. HSV was isolated either on day 2 or day 7 in seven of ten cases using Ara-A and in eight of nine cases using the placebo ointment; in the remainder the ulcers had healed or were not sampled. There was reasonable correlation between the results of virus 
